Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical TrialsMarcella Sarzotti‐Kelsoe, Anita Simkins, Josephine H. Cox et al.|PLoS Medicine|2009Cited by 59
A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C-Modified Vaccinia Ankara Virus Vaccine Candidate in Indian VolunteersVadakkuppatu Devasenapathi Ramanathan, Patricia Fast, Dennis Panicali et al.|AIDS Research and Human Retroviruses|2009Cited by 59
P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trialsMarcella Sarzotti‐Kelsoe, Anita Simkins, Josephine H. Cox et al.|Retrovirology|2009Cited by 5